نتایج جستجو برای: تومور مارکر ca125

تعداد نتایج: 5813  

Journal: :Gynecologic oncology 2007
Iris Simon Dionyssios Katsaros Irene Rigault de la Longrais Marco Massobrio Andreas Scorilas Nam W Kim Mark J Sarno Robert L Wolfert Eleftherios P Diamandis

OBJECTIVE This study characterizes the expression of the novel biomarker B7-H4 in ovarian cancer tissue, normal ovaries, and benign ovarian tumors, and evaluates its relationship to CA125. METHODS Ovarian tissue lysates from 251 patients with ovarian carcinoma were assessed for the levels of B7-H4 and CA125 by ELISA assays. For comparison, ovarian tissues from patients with benign ovarian tum...

ژورنال: :مجله دانشگاه علوم پزشکی کردستان 0
مریم مرادی نسب maryam moradi nasab department of biology, faculty of natural sciences, tabriz university, tabriz, iran.کارشناس ارشد ژنتیک ، دانشکده علوم طبیعی ، دانشگاه تبریز، تبریز، ایران. محمد علی حسینپور فیضی mohammad ali hossein pour feizi biology dept., faculty of natural sciences, tabriz university, tabriz, iranگروه رادیوبیولوژی، دانشکده علوم طبیعی، دانشگاه تبریز، تبریز، ایران ریحانه روانبخش گاوگانی reyhaneh ravanbakhsh gavgani department of biology, faculty of natural sciences, tabriz university, tabriz, iran.کارشناس ارشد ژنتیک ، دانشکده علوم طبیعی ، دانشگاه تبریز، تبریز، ایران. ناصر پولادی naser pouladi cellular and molecular biology dept., azarbaijan shahid madani university, tabriz, iran.زیست شناسی سلولی و ملکولی، دانشکده علوم، گروه زیست شناسی دانشگاه شهید مدنی آذربایجان، تبریز، ایران. آئیدا صدرایی بناب aeeda sedaie bonab department of biology, faculty of natural sciences, tabriz university, tabriz, iran.کارشناس ارشد ژنتیک ، دانشکده علوم طبیعی ، دانشگاه تبریز، تبریز، ایران. پروین آذرفام parvin azarfam department of biology, faculty of natural sciences, tabriz university, tabriz, iran.کارشناس ارشد فیزیک پزشکی، دانشکده علوم طبیعی، دانشگاه تبریز، تبریز، ایران. وحید منتظری

سابقه و هدف : ژن tp63، بعنوان قدیمی ترین همولوگ tp53، دو واریانت n-ترمینالی اصلی را بوسیله ی پروموتور های مختلف کد می کند : واریانت tap63 با فعالیت سرکوبگری تومور و δnp63 با فعالیت انکوژنی. در اثر حذف اگزون شماره ی 4 هر یک از واریانت های مذکور، دو واریانت n-ترمینالی دیگر نیز در دهه ی گذشته برای p63 گزارش شد :d4tap63 و δnp73l ، اما همچنان عملکرد دقیق این واریانت ها در سلول های سالم و توموری مشخص...

Journal: :The Medical journal of Malaysia 2006
S H How C K Liam A R Jamalludin S P Chin A B Zal

We studied the prevalence of raised serum CA125 in patients with pleural effusions and explored factors affecting its level. Sixty four patients with benign effusions and 36 patients with malignant effusions admitted to the University Malaya Medical Centre from May 2001 to January 2002 were included in the study. There were no significant differences in age, gender and ethnicity of the patients...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011
B You O Colomban M Heywood C Lee M Davy N Reed S Pignata R Fossati G Emons K L Rehman K D Steffensen E Petru V Gebski A Burges N Tubiana-Matthieu M Hansen P A Vasey U Denison P De Bruyne A M Oza

5065 Background: Although CA125 kinetic profiles may be related with relapse risk in ovarian cancer patients treated with chemotherapy, no reliable kinetic parameters have been reported. Mathematical modeling may help describe CA125 decline dynamically and determine parameters predictive of relapse. METHODS Data from CALYPSO phase III trial data comparing 2 carboplatin-based regimens in ROC p...

2017
Na Guo Zhilan Peng

BACKGROUND The detection of CA125 has been used in the follow up of ovarian cancer. At present, some scholars believe that serum CA125 has no clinical value for the follow-up monitoring the recurrence for postoperative patients with epithelial ovarian cancer, but in our clinical follow-up found that when the serum CA125 value is <35 U/ml, postoperative patients of epithelial ovarian carcinoma h...

2015
Julio Núñez Gabriel A. Rabinovich Justo Sandino Luis Mainar Patricia Palau Enrique Santas Maria Pilar Villanueva Eduardo Núñez Vicent Bodí Francisco J. Chorro Gema Miñana Juan Sanchis

AIMS Galectin-3 (Gal-3) and carbohydrate antigen 125 (CA125) have emerged as robust prognostic biomarkers in heart failure. Experimental data have also suggested a potential molecular interaction between CA125 and Gal-3; however, the biological and clinical relevance of this interaction is still uncertain. We sought to evaluate, in patients admitted for acute heart failure, the association betw...

2009
Mongkol Benjapibal Suthi Sangkarat Somsak Laiwejpithaya Boonlert Viriyapak Pattama Chaopotong Atthapon Jaishuen

An elevated serum CA125 level in association with a pelvic mass, pleural effusion, and massive ascites usually signifies a dismal prognosis in a postmenopausal woman. However, surgery and histopathological examination are required for the correct diagnosis and treatment, since an elevated CA125 level can be falsely positive for ovarian malignancy. We present a case of Meigs' syndrome due to rig...

Journal: :European journal of heart failure 2012
Julio Núñez Eduardo Núñez Gema Miñana Vicent Bodí Gregg C Fonarow Vicente Bertomeu-González Patricia Palau Pilar Merlos Silvia Ventura Francisco J Chorro Pau Llàcer Juan Sanchis

AIMS Recent observations in chronic stable heart failure suggest that high-dose loop diuretics (HDLDs) have detrimental prognostic effects in patients with high blood urea nitrogen (BUN), but recent findings have also indicated that diuretics may improve renal function. Carbohydrate antigen 125 (CA125) has been shown to be a surrogate of systemic congestion. We sought to explore whether BUN and...

Journal: :Advances in peritoneal dialysis. Conference on Peritoneal Dialysis 2002
Misaki Moriishi Hideki Kawanishi Tooru Kawai Syunsake Takahashi Takayuki Hirai Masayaki Shishida Hiroshi Watanabe Naoko Takahashi

We evaluated the influence of a neutral peritoneal dialysis solution (PDS) on the peritoneum. The subjects were 10 stable PD patients using conventional PDS. We substituted pH-neutral PDS (PD Solita A: Shimizu Medical, Tokyo, Japan) for conventional PDS (Gambrosol A: Shimizu Medical). Effluent from 4-hour dwells was collected, and the appearance rate of cancer antigen 125 (CA125-AR) was calcula...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001
D K Pauler U Menon M McIntosh H L Symecko S J Skates I J Jacobs

Our objective was to identify factors that correlate with CA125 concentrations in healthy postmenopausal women and to introduce recommendations for reporting and interpreting individual CA125 assay results. We analyzed repeated serum CA125 levels, as measured by the CA125II assay, in 18,748 postmenopausal women who participated in the ST: Bartholomew's/Royal London Hospital Ovarian Cancer scree...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید